Pmv Pharmaceuticals Inc (PMVP)

May 05, 2025

PMV Pharmaceuticals Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView

May 05, 2025

May 03, 2025

JPMorgan Chase & Co. Sells 2,250 Shares of Fidelity MSCI Consumer Discretionary Index ETF (NYSEARCA:FDIS) - Defense World

May 03, 2025

Apr 30, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.32 - MSN

Apr 30, 2025

Apr 26, 2025

ConocoPhillips (NYSE:COP) Receives Average Recommendation of “Buy” from Analysts - American Banking and Market News

Apr 26, 2025

Apr 26, 2025

APA Group (OTCMKTS:APAJF) Stock Price Down 9.1% – Here’s What Happened - Defense World

Apr 26, 2025

Apr 26, 2025

XP Power (OTCMKTS:XPPLF) Trading Down 12% – Should You Sell? - Defense World

Apr 26, 2025

Apr 26, 2025

PMV Pharmaceuticals (NASDAQ:PMVP) Stock Price Down 3.7% – Should You Sell? - Defense World

Apr 26, 2025

Apr 26, 2025

Dunxin Financial (NYSEAMERICAN:DXF) Stock Price Up 5.6% – Here’s What Happened - Defense World

Apr 26, 2025

Apr 26, 2025

Molecular Partners (OTCMKTS:MLLCF) Shares Down 1.4% – Should You Sell? - Defense World

Apr 26, 2025

Apr 15, 2025

PMV Pharmaceuticals patents new TP53 stabilizers - BioWorld MedTech

Apr 15, 2025

Apr 10, 2025

Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors - Business Wire

Apr 10, 2025

Apr 08, 2025

Promising Biotech Stocks To Watch Now – April 6th - Defense World

Apr 08, 2025

Apr 01, 2025

PMVP stock touches 52-week low at $1.01 amid market challenges - Investing.com Australia

Apr 01, 2025

Mar 25, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.2 amid market shifts - Investing.com

Mar 25, 2025

Mar 23, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025

Mar 22, 2025

HC Wainwright Reiterates “Buy” Rating for PMV Pharmaceuticals (NASDAQ:PMVP) - Defense World

Mar 22, 2025

Mar 21, 2025

Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace

Mar 21, 2025

Mar 12, 2025

PMVP stock touches 52-week low at $1.2 amid market challenges - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

PMVP stock touches 52-week low at $1.2 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 05, 2025

Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing - Nasdaq

Mar 05, 2025

Mar 03, 2025

PMV Pharmaceuticals Reports Progress in Clinical Trials - TipRanks

Mar 03, 2025

Mar 03, 2025

PMV Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2025

Mar 03, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.32 By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - The Manila Times

Mar 03, 2025

Mar 03, 2025

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire

Mar 03, 2025

Feb 27, 2025

PMV Pharmaceuticals (PMVP) Expected to Announce Quarterly Earnings on Thursday - Defense World

Feb 27, 2025

Feb 26, 2025

3 US Penny Stocks To Consider In February 2025 - simplywall.st

Feb 26, 2025

Feb 24, 2025

PMV Pharmaceuticals Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView

Feb 24, 2025

Feb 24, 2025

Perceive Pharma: $15 Million (Series A) Raised For Advancing Ophthalmic Neuroprotection - Pulse 2.0

Feb 24, 2025

Feb 20, 2025

PMVP Stock Sees Surge of Approximately 2.86% in Last Five Days - Knox Daily

Feb 20, 2025

Feb 19, 2025

Catalio Capital Management Joins $15 Million Series A for Perceive Pharma - citybiz

Feb 19, 2025

Feb 18, 2025

Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection - PR Newswire

Feb 18, 2025

Feb 14, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Significant Drop in Short Interest - MarketBeat

Feb 14, 2025

Feb 12, 2025

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results - br.ADVFN.com

Feb 12, 2025

Feb 11, 2025

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire

Feb 11, 2025

Feb 11, 2025

PMVP's Top Executives Set to Reveal Latest Oncology Developments at Major Healthcare Conferences - StockTitan

Feb 11, 2025

Jan 28, 2025

US Penny Stocks To Watch In January 2025 - Simply Wall St

Jan 28, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Reduces Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 26, 2025

Jan 26, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 26, 2025

Jan 25, 2025

Barclays PLC Trims Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 25, 2025

Jan 25, 2025

Barclays PLC Trims Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Jan 25, 2025

Jan 15, 2025

Jane Street Group LLC Sells 89,957 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 15, 2025

Jan 15, 2025

Jane Street Group LLC Sells 18,128 Shares of New Found Gold Corp. (NYSE:NFGC) - Defense World

Jan 15, 2025

Jan 13, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.4 amid market challenges - Investing.com India

Jan 13, 2025